Laboratory Evolution of P450 BM-3 for Mediated Electron Transfer

International University Bremen, Campus Ring 8, 28759 Bremen, Germany.
ChemBioChem (Impact Factor: 3.06). 04/2006; 7(4):638-44. DOI: 10.1002/cbic.200500436
Source: PubMed

ABSTRACT Preparative synthesis with P450 monooxygenases is hampered in cell-free systems by the requirement for cofactors such as NAD(P)H as reduction equivalents. A validated medium-throughput screening system was designed for improving P450 monooxygenases by mediated electron transfer with zinc/cobalt(III)sepulchrate (Zn/Co(III)sep) as an alternative and cost-effective cofactor system. The monooxygenase P450 BM-3 F87A was used as a model system for developing the screening system in a 96-well format. A coefficient of variation of less than 10% was achieved under optimized screening conditions. The mediator evolution screen was validated by comparing the activity of P450 BM-3 to P450 BM-3 F87A and by screening a saturation mutagenesis library at amino acid position R47. For mediated electron transfer, two double mutants P450 BM-3(F87A R47F) and P450 BM-3 (F87A R47Y) were identified with a two-threefold increased catalytic efficiency (up to 32 microM(-1) min(-1) for P450 BM-3(F87A R47F) and 34 microM(-1) min(-1) for P450 BM-3 (F87A R47Y)) compared to P450 BM-3 F87A. The kinetic constants of the double mutants are, in contrast to those of P450 BM-3 F87A, dependent on Co(III)sep concentration in the presence of NADPH. kcat increases from 145 min(-1) (0.25 mM Co(III)sep) to 197 min(-1) (0.5 mM Co(III)sep), and Km decreases simultaneously from 7.0 microM to 3.7 microM, for P450 BM-3 (F87A R47F). For P450 BM-3 (F87A R47Y), kcat increases from 138 min(-1) (0.25 mM Co(III)sep) up to 187 min(-1) (0.5 mM Co(III)sep), and Km decreases from 8.2 microM to 4.2 microM. Due to lower Km values, the catalytic efficiencies were improved six times for P450 BM-3 (F87A R47F) and three times for P450 BM-3 (F87A R47Y), when comparing catalytic efficiencies of the mediated electron-transfer system to the natural reduction equivalent NADPH.

  • [Show abstract] [Hide abstract]
    ABSTRACT: The application of cobalt sepulchrate (sep) complexes as active and robust homogeneous catalysts is reported here for the first time, as well as the crystal structure of the [Co(sep)]2(SO4)3·10H2O compound. The reaction chosen to investigate the catalytic performance of these catalysts was the oxidation of styrene due to the importance of its products in various industrial applications. Sustainable experimental conditions were selected, using H2O2 as the oxidant and ionic liquids as solvents. A similar catalytic activity was found using complexes containing different anions: [Co(sep)]Cl3 and [Co(sep)]2(SO4)3. Different kinetic profiles were found using different ionic liquids (1-butyl-3-methylimidazolium hexafluorophosphate or tetrafluoroborate) or acetonitrile as solvents. Complete conversions were achieved after 24 h of reaction. Benzaldehyde was the main product formed and in some cases the only one observed. The homogeneous cobalt catalysts using an ionic liquid as solvent could be recycled for consecutive cycles without significant loss of activity. In addition, the stability of the cobalt sepulchrate complex was confirmed by 1H NMR after catalytic use.
    New Journal of Chemistry 05/2014; 38(6). DOI:10.1039/C4NJ00120F · 3.16 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Cost-efficient production of sustainably-derived biochemicals and biofuels is a critical goal of modern biotechnology. The current predominant biotransformation method is mainly based on microbial fermentation, but this system suffers from a mismatch of engineering and cellular objectives, appropriates a significant fraction of substrate/energy sources for self-replication, and poses significant scaling challenges. Cell-free biosystems for biomanufacturing (CFB2)—complex, cell-free systems that catalyze the conversion of renewable substrates to a variety of products—are emerging as an alternative to fermentation. Within this burgeoning field, a new application is the production of low-value and high-impact biocommodities by CFB2. In this subset, synthetic enzymatic networks are capable of producing numerous desired biocommodities, with the advantages of higher product yields, faster reaction rates, and reduced interference from toxic compounds, among others. In this review, CFB2, with an emphasis on biocommodities production, is compared with microbial fermentation; current applications are presented, illustrating some of the advantages of the system; and remaining challenges are discussed with the path forward for each.
    Green Chemistry 06/2013; 15(7):-. DOI:10.1039/C3GC40625C · 6.85 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: A series of 2-hydroxy-2-(4-oxo-1,2-diaryl-4,5,6,7-tetrahydro-1H-3-indolyl)-2-cyanoacetamides have been synthesized through selective C H oxidation of active methylene carbon of cyanoacetamide derivatives using tert-butyl hydroperoxide as oxidant and ferric chloride as radical initiator. In this reaction the tert-butyl oxo radical abstracts hydrogen from the active methylene group of 2-pyrolyl-2-cyanoacetamides to generate a stable captodative radical intermediate. Then recombination of this radical intermediate with tert-butyl oxo radical followed by acid catalysed thermal elimination of the tert-butyl group produces the quaternary hydroxyl cyanoacetamide derivatives in good yield.
    Tetrahedron Letters 10/2014; 55(41):5676–5679. DOI:10.1016/j.tetlet.2014.08.074 · 2.39 Impact Factor